Correa-Rocha R, Lopez-Abente J, Gutierrez C, Pérez-Fernández VA, Prieto-Sánchez A, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Plos One 2018. 13(8): . Nº de citas: 16

[doi:10.1371/journal.pone.0203419]

Rivero, Antonio, Polo, Rosa, Lopez Aldeguer, Jose, Lozano, Fernando, Antela, Antonio, Ramon Arribas, Jose, Asensi, Victor, Berenguer, Juan, Ramon Blanco, Jose, Luis Casado, Jose, Clotet, Bonaventura, Crespo, Manuel, Domingo, Pere, Duenas, Carlos, Maria Gatell, Jose, Luis Gomez-Sirvent, Juan, Gonzalez-Garcia, Juan, Antonio Iribarren, Jose, Bernaldo de Quiros, Juan Carlos Lopez, Lopez Cortes, Luis Fernando, Emilio Losa, Juan, Mallolas, Josep, Marino, Ana, Martinez, Esteban, Miro, Jose M., Moreno, Santiago, Palacios, Rosario, Pasquau, Juan, Antonio Pineda, Juan, Podzamczer, Daniel, Portilla, Joaquin, Poveda, Eva, Pulido, Federico, Rubio, Rafael, Santos, Jesus, Sanz Moreno, Jose, Sanz Sanz, Jesus, Jesus Tellez, Maria, de la Torre, Javier, Tuset, Montserrat, Perez Molina, Jose A..

Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36(7): 435-445. Nº de citas: 2

[doi:10.1016/j.eimc.2017.04.001]

Salzer HJF, Stoney RJ, Angelo KM, Rolling T, Grobusch MP, Libman M, López-Vélez R, Duvignaud A, Ásgeirsson H, Crespillo-Andújar C, Schwartz E, Gautret P, Bottieau E, Jordan S, Lange C, Hamer DH, GeoSentinel Surveillance Network.

Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017.

JOURNAL OF TRAVEL MEDICINE 2018. 25(1): .

[doi:10.1093/jtm/tay055]

González-García A, Carpintero L, Fortún J, Navas-Elorza E, Martín-Dávila P, Moreno S.

Changes in tuberculosis in human immunodeficiency virus infected patients in a Spanish tertiary hospital (1995-2013).

REVISTA ESPANOLA DE QUIMIOTERAPIA 2018. 31(4): 329-335. Nº de citas: 1

Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA, RDI Data and Study Group.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

The Journal of antimicrobial chemotherapy 2018. 73(8): 2186-2196.

[doi:10.1093/jac/dky179]

Vázquez-Castellanos JF, Serrano-Villar S, Jiménez-Hernández N, Soto Del Rio MD, Gayo S, Rojo D, Ferrer M, Barbas C, Moreno S, Estrada V, Rattei T, Latorre A, Moya A, Gosalbes MJ.

Interplay between gut microbiota metabolism and inflammation in HIV infection.

ISME JOURNAL 2018. 12(8): 1964-1976. Nº de citas: 31

[doi:10.1038/s41396-018-0151-8]

Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C.

Candida periprosthetic joint infection: A rare and difficult-to-treat infection.

JOURNAL OF INFECTION 2018. 77(2): 151-157. Nº de citas: 11

[doi:10.1016/j.jinf.2018.03.012]

Blanco JR, Alejos B, Moreno S.

Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018. 24(8): 900-907. Nº de citas: 9

[doi:10.1016/j.cmi.2017.11.016]

Cuypers L, Pérez AB, Chueca N, Aldamiz-Echevarría T, Alados JC, Martínez-Sapiña AM, Merino D, Pineda JA, Téllez F, Espinosa N, Salméron J, Rivero-Juarez A, Vivancos MJ, Hontañón V, Vandamme AM, García F.

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Plos One 2018. 13(7): . Nº de citas: 7

[doi:10.1371/journal.pone.0201268]

Fortún J, Gioia F, Muñoz P, Graus J, Gómez-García de la Pedrosa E, Martín-Dávila P, Saiz A, Vena A, Moreno S.

T2 magnetic resonance for the diagnosis of deep-seated invasive candidiasis in a liver recipient without candidemia.

REVISTA IBEROAMERICANA DE MICOLOGIA 2018. 35(3): 159-161.

[doi:10.1016/j.riam.2018.03.002]

Páez-Vega A, Poyato A, Rodriguez-Benot A, Guirado L, Fortún J, Len O, Abdala E, Fariñas MC, Cordero E, de Gracia C, Hernández D, González R, Torre-Cisneros J, Cantisán S, Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016), Spanish Renal Disease Network (REDinREN, RD16/0009).

Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.

ANTIVIRAL RESEARCH 2018. 155: 97-105. Nº de citas: 4

[doi:10.1016/j.antiviral.2018.05.006]

Berenguer J, Gil-Martin Á, Jarrin I, Moreno A, Dominguez L, Montes M, Aldámiz-Echevarría T, Téllez MJ, Santos I, Benitez L, Sanz J, Ryan P, Gaspar G, Alvarez B, Losa JE, Torres-Perea R, Barros C, San Martin JV, Arponen S, de Guzmán MT, Monsalvo R, Vegas A, Garcia-Benayas MT, Serrano R, Gotuzzo L, Menendez MA, Belda LM, Malmierca E, Calvo MJ, Cruz-Martos E, González-García JJ.

All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings.

HEPATOLOGY 2018. 68(1): 32-47. Nº de citas: 44

[doi:10.1002/hep.29814]

Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, Falces C, Gonzalez Rico C, Kortajarena Urkola X, Lepe JA, Rodriguez Alvarez R, Reguera Iglesias JM, Navas E, Dominguez F, Garcia-Pavia P.

Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2018. 71(24): 2731-2740. Nº de citas: 39

[doi:10.1016/j.jacc.2018.03.534]

Deusch S, Serrano-Villar S, Rojo D, Martínez-Martínez M, Bargiela R, Vázquez-Castellanos JF, Sainz T, Barbas C, Moya A, Moreno S, Gosalbes MJ, Estrada V, Seifert J, Ferrer M.

Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.

AIDS 2018. 32(10): 1229-1237. Nº de citas: 15

[doi:10.1097/QAD.0000000000001831]

Valencia J, Ryan P, Alvaro-Meca A, Troya J, Gutierrez J, Cuevas G, Moreno S.

High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis.

AIDS 2018. 32(9): 1157-1163. Nº de citas: 1

[doi:10.1097/QAD.0000000000001806]

Casado JL, Monsalvo M, Rojo AM, Fontecha M, Rodriguez-Sagrado MA.

Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY 2018. 11(6): 561-570.

[doi:10.1080/17512433.2018.1478726]

Aguado R, Páez-Vega A, Agüera ML, Montejo M, Guirado L, Fortún J, Suárez-Benjumea A, Len O, Fariñas MC, de Gracia C, Hernández D, Cobos-Ceballos MJ, Torre-Cisneros J, Cantisán S.

Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients.

HUMAN IMMUNOLOGY 2018. 79(6): 499-505. Nº de citas: 3

[doi:10.1016/j.humimm.2018.03.009]

Reinwald M, Silva JT, Mueller NJ, Fortún J, Garzoni C, de Fijter JW, Fernández-Ruiz M, Grossi P, Aguado JM.

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018. 24 Suppl 2: 53-70. Nº de citas: 83

[doi:10.1016/j.cmi.2018.02.009]